Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.


Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations


Tolle, M.A. (2009) Mosquito-Borne Diseases. Current Problems in Pediatric and Adolescent Health Care, 39, 97-140. S1538-5442(09)00014-5 [pii]

has been cited by the following article:

  • TITLE: From Culex Exposure to West Nile Virus Infection: Screening of Specific Biomarkers

    AUTHORS: Mahfoud Bakli, Christophe Fraisier, Lionel Almeras

    KEYWORDS: West Nile Virus, Culex, Biomarker, Salivary Protein, Antibody Response, Vector Control

    JOURNAL NAME: Open Journal of Veterinary Medicine, Vol.4 No.7, July 29, 2014

    ABSTRACT: West Nile virus (WNV) is a mosquito-borne flavivirus contributing yearly, to birds, horses and human morbidity and mortality throughout the world. WNV is transmitted mainly by mosquitoes, predominantly by Culex species, to avian hosts and other vertebrates. Since the mid-1990s, WNV outbreaks and severe human cases (i.e., West Nile neuroinvasive disease) have increased throughout the North hemisphere. The absence of human vaccine and effective therapy needs to understand the pathogenesis of WN severe disease as well as factors participating in WNV transmission and mosquito exposure. The exploration of the host/vector interaction at the individual level using host antibody response against mosquito salivary proteins has open news research opportunities aiming to increase the impact of surveillance and WNV vector control strategies. This review describes Culex saliva specific biomarkers as a helpful tool to estimate exposure to vector bites and risk for WNV infection, summarizes recent advances regarding WNV vector control strategies and highlights potential specific biomarkers of WN disease severity.